2025: Stem cell breakthroughs could change life with Type-1 diabetes
Big news for anyone touched by Type-1 diabetes—scientists are making real progress with stem cell therapies that could replace the insulin-producing cells lost in the disease.
If these advances keep up, daily insulin shots might soon be a thing of the past.
New treatments bring hope for a real cure
The FDA has already approved Lantidra, which uses donor cells to help people regain insulin independence, specifically for a narrow high-risk subgroup.
Vertex's Zimislecel therapy uses lab-grown islet cells for similar results.
And CRISPR Therapeutics' VCTX-211 is taking things further by using gene editing to stop immune rejection—meaning less need for harsh meds.
In a study of Zimislecel, most patients didn't need insulin at all a year after treatment.
It's an exciting time, with real hope on the horizon for easier diabetes management.